What are the recommended doses of isoniazid and rifampin for treating latent tuberculosis infection in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Doses of Rifampin and Isoniazid for Latent Tuberculosis Infection

For latent TB treatment, use rifampin 10 mg/kg daily (maximum 600 mg) for adults and 10-20 mg/kg daily (maximum 600 mg) for children, OR isoniazid 5 mg/kg daily (maximum 300 mg) for adults and 10-15 mg/kg daily (maximum 300 mg) for children, with specific dosing depending on your chosen regimen. 1, 2

Preferred Treatment Regimens and Dosing

The 2020 CDC/NTCA guidelines establish three preferred regimens, each with specific dosing 3:

1. Three Months of Daily Isoniazid Plus Rifampin (3HR)

  • Adults: Isoniazid 5 mg/kg (max 300 mg) + Rifampin 10 mg/kg (max 600 mg) daily 1, 2
  • Children: Isoniazid 10-15 mg/kg (max 300 mg) + Rifampin 10-20 mg/kg (max 600 mg) daily 1, 2
  • Duration: 3 months (12 weeks)
  • Evidence level: Conditional recommendation with very low certainty for HIV-negative, low certainty for HIV-positive 3

This regimen is particularly effective in children under 15 years, showing equivalent efficacy to 6-month isoniazid with no difference in adverse effects or hepatotoxicity 3.

2. Four Months of Daily Rifampin Alone (4R)

  • Adults and Children: Rifampin 10 mg/kg daily (max 600 mg) 1
  • Duration: 4 months (16 weeks)
  • Evidence level: Strong recommendation with moderate certainty for HIV-negative patients 3

This is the preferred monotherapy option due to significantly lower hepatotoxicity compared to isoniazid regimens and higher completion rates 3, 4. Recent data shows 94% completion rates with rifampin versus 69% with isoniazid in kidney transplant candidates 4.

3. Three Months of Weekly Isoniazid Plus Rifapentine (3HP)

  • Adults and Children >2 years:
    • Isoniazid 15 mg/kg (max 900 mg) weekly
    • Rifapentine 900 mg (for adults >50 kg) weekly
  • Duration: 12 doses over 3 months
  • Evidence level: Strong recommendation with moderate certainty 3

This regimen requires approximately 10 pills taken simultaneously once weekly 3.

Alternative Regimens

Six Months of Daily Isoniazid (6H)

  • Adults: Isoniazid 5 mg/kg (max 300 mg) daily 2
  • Children: Isoniazid 10-15 mg/kg (max 300 mg) daily 2
  • Evidence level: Strong for HIV-negative, conditional for HIV-positive 3

Nine Months of Daily Isoniazid (9H)

  • Adults: Isoniazid 5 mg/kg (max 300 mg) daily 2
  • Children: Isoniazid 10-15 mg/kg (max 300 mg) daily 2
  • Evidence level: Conditional recommendation 3

Intermittent Dosing Options

For directly observed therapy when daily administration is not feasible 2:

Twice or Three Times Weekly:

  • Adults: Isoniazid 15 mg/kg (max 900 mg) per dose 2
  • Children: Isoniazid 20-40 mg/kg (max 900 mg) per dose 2

Critical Dosing Considerations

Administration Timing

Rifampin must be taken on an empty stomach: 1 hour before or 2 hours after meals with a full glass of water 1. This is essential for optimal absorption.

Pyridoxine Supplementation

Add pyridoxine (vitamin B6) 10 mg daily when using isoniazid in 2:

  • Malnourished patients
  • Diabetics
  • Alcoholics
  • Pregnant/lactating women
  • Those predisposed to neuropathy

Drug Interactions

Rifampin significantly induces hepatic metabolism, affecting 3:

  • Warfarin
  • Oral contraceptives
  • Azole antifungals
  • HIV antiretroviral therapy (especially protease inhibitors and NNRTIs)

Consider rifabutin as an alternative when rifampin interactions are problematic 3.

Hepatotoxicity Risk

The combination of isoniazid plus rifampin carries greater hepatotoxicity risk than either drug alone 3. However, 4-month rifampin monotherapy shows significantly lower hepatotoxicity than isoniazid regimens—4.6% versus 32.9% in recent data 5.

Special Populations

HIV-Positive Patients

Use the same dosing as HIV-negative patients, but carefully evaluate antiretroviral drug interactions 3. The 3HR regimen has conditional recommendation with low certainty evidence for this population 3.

Pregnancy

All drugs (rifampin, isoniazid, ethambutol, pyrazinamide) can be used during pregnancy at standard doses 2. Avoid streptomycin due to fetal ototoxicity. Always add prophylactic pyridoxine 10 mg daily 2.

Renal Failure

Rifampin dosing typically does not require adjustment 1. For isoniazid, adjust doses based on creatinine clearance, particularly in severe renal impairment 2.

Common Pitfalls to Avoid

  1. Do not use 2 months of rifampin and pyrazinamide in non-HIV-infected adults—this regimen causes unacceptably high rates of severe hepatotoxicity 6

  2. Ensure active TB is excluded before starting LTBI treatment—inadequate exclusion can lead to acquired drug resistance 3

  3. Monitor for systemic drug reactions with 3HP—20.1% require hospitalization, though reactions are self-limited and no deaths have been reported 3

  4. Do not assume completion rates are equivalent—shorter regimens have significantly higher completion: 3HP achieves 97.8% versus 67.6% for 6H 5, and 4R achieves 93.8% versus 84.1% for 6H/9H 7

Practical Algorithm for Regimen Selection

First-line choice: 4 months daily rifampin (4R) for most patients—highest completion rates, lowest hepatotoxicity, simplest dosing 3, 4

If rifampin contraindicated (drug interactions): Consider 3HP if directly observed therapy available, or 6H/9H if not 3

For children <2 years: Use 3HR or 6H (3HP not studied in this age group) 3

For adherence concerns: Prioritize 3HP with directly observed therapy or 4R over longer isoniazid regimens 8, 7

Related Questions

Is the combination of isoniazid and rifapentine appropriate for treating latent tuberculosis infection?
What are the recommended treatment regimens for latent tuberculosis infection?
What is the recommended dose of isoniazid (with pyridoxine) for latent tuberculosis treatment?
What is the recommended treatment regimen for a patient with cavitary tuberculosis, considering factors such as weight, kidney function, and HIV status?
Why shouldn't HRZE (isoniazid, rifampin, pyrazinamide, ethambutol) be used for latent tuberculosis infection in a patient with a positive tuberculin skin test, normal chest radiograph, and negative sputum cultures?
What is the recommended management for a 73‑year‑old woman with advanced bilateral hip osteoarthritis, associated lumbar spine and sacroiliac joint degenerative changes, and mild levoconvex lumbar scoliosis?
When does the peak plasma concentration occur after an Invega (paliperidone palmitate) injection?
What is the appropriate evaluation and management for a patient with ten days of persistent nausea without red‑flag symptoms?
Is trimethoprim‑sulfamethoxazole double‑strength (Septra DS) appropriate for a 77‑year‑old patient with a Klebsiella infection?
What GABA‑receptor medications can be added to a patient who is currently taking lorazepam (Ativan)?
In a 74-year-old nursing-home resident with epilepsy, depression, insomnia, chronic delusional disorder, and currently on levetiracetam, would Depakote (divalproex sodium) be an appropriate treatment option if he were found to have undiagnosed bipolar disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.